Find the latest episode of "The Uncertain Hour" here. Listen

Another pharma megamerger: AbbVie buys Allergan for $63 billion

Erika Beras Jun 25, 2019
HTML EMBED:
COPY
PHILIPPE HUGUEN/AFP/Getty Images

Another pharma megamerger: AbbVie buys Allergan for $63 billion

Erika Beras Jun 25, 2019
PHILIPPE HUGUEN/AFP/Getty Images
HTML EMBED:
COPY

Earlier this year, Bristol-Myers Squibb announced it was buying Celgene for $74 billion. Now AbbVie, which makes popular drug Humira, has entered into an agreement to pay about $63 billion for Allergan, the manufacturer of Botox. What’s in it for both companies?

Click the audio player above to hear the full story.

Marketplace is on a mission.

We believe Main Street matters as much as Wall Street, economic news is made relevant and real through human stories, and a touch of humor helps enliven topics you might typically find…well, dull.

Through the signature style that only Marketplace can deliver, we’re on a mission to raise the economic intelligence of the country—but we don’t do it alone. We count on listeners and readers like you to keep this public service free and accessible to all. Will you become a partner in our mission today?

Your donation is critical to the future of public service journalism. Support our work today – for as little as $5 – and help us keep making people smarter.